-
1 Comment
Shionogi & Co., Ltd is currently in a long term uptrend where the price is trading 2.8% above its 200 day moving average.
From a valuation standpoint, the stock is 91.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
Shionogi & Co., Ltd's total revenue sank by 18.0% to $76B since the same quarter in the previous year.
Its net income has dropped by 6.5% to $37B since the same quarter in the previous year.
Finally, its free cash flow fell by 42.7% to $6B since the same quarter in the previous year.
Based on the above factors, Shionogi & Co., Ltd gets an overall score of 2/5.
| Exchange | TSE |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | JPY |
| ISIN | JP3347200002 |
| PE Ratio | 11.89 |
|---|---|
| Beta | 0.03 |
| Market Cap | 2T |
| Target Price | 3395.8333 |
| Dividend Yield | 2.5% |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4507.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026